Descargar PDF

Otros usuarios también vieron estos artículos

SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA Aloña Agirre-Lizaso; Maider Huici-Izagirre; Colm J. O¿Rourke; Ekaterina Zhuravleva; Ana Korosec; Mikel Azkargorta; Felix Elortza; Javier Vaquero; Sumera I. Ilyas; Gregory J. Gores; Jesper B. Andersen; Gernot Schabbauer; Luis Bujanda; Pedro M. Rodrigues; Omar Sharif; Jesus M. Banales; Maria J. Perugorria;
Gastroenterol Hepatol. 2023;46 Supl 3:S4
178 - THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER- SUMOYLATION IN CHOLANGIOCARCINOMA Paula Olaizola; Irene Olaizola; Marta Fernández de Ara; Maite G. Fernández-Barrena; Laura Alvarez; Mikel Azkargorta; Colm J. O¿Rourke; Pui-Yuen Lee-Law; Luiz Miguel Nova-Camacho; Jose J.G. Marin; Maria L. Martínez-Chantar; Matias A. Avila; Patricia Aspichueta; Felix Elortza; Jesper B. Andersen; Luis Bujanda; Pedro M. Rodrigues; Maria J. Perugorria; Jesus M. Bañales;
Gastroenterol Hepatol. 2023;46 Supl 3:S210
159 - KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR Pedro Miguel Rodrigues; Oihane Erice; Ana Landa-Magdalena; Nuno André Paiva; Maite García Fernández-Barrena; Paula Olaizola; Ainhoa Lapitz; Colm J. O¿Rourke; Jesper B. Andersen; Diego F. Calvisi; Mikel Azkargorta; Felix Elortza; Ibai Goicoechea; Charles H. Lawrie; Luis Bujanda; María Jesús Perugorria; Jesús María Bañales;
Gastroenterol Hepatol. 2023;46 Supl 3:S191